Johnson & Johnson Says Tremfya Psoriatic Arthritis Trial Meets Endpoints
Johnson & Johnson said a Phase 4 trial of Tremfya in psoriatic arthritis met its endpoints.
Johnson & Johnson said a Phase 4 trial of Tremfya in psoriatic arthritis met its endpoints.